At the dawn of biosimilar insulins

The European Medicines Agency introduced the term 'biosimilars' into their legislation in 2004 to allow for marketing authorisation of biological therapeutics and in 2014 Abasria® was approved for the treatment of type 1 and type 2 diabetes

Source: Pharmacy Europe - February 16, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Diabetes Featured Articles Source Type: news